Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk

TF Chao, YH Chan, CE Chiang, TC Tuan… - … Journal-Quality of …, 2022 - academic.oup.com
… The Edoxaban Low-Dose for EldeR CARE AF patients (… that in very elderly Japanese patients
with non-valvular AF who were … other DOACs (dabigatran, rivaroxaban, and apixaban) with …

Anti-factor Xa activity of standard and Japan-specific doses of rivaroxaban in Thai patients with non-valvular atrial fibrillation

W Wongcharoen, P Pacharasupa… - Circulation …, 2020 - jstage.jst.go.jp
… for the management of patients with atrial fibrillation: Executive sum… Bleeding risk of apixaban,
dabigatran, and low-dose rivar… with warfarin in Japanese patients with nonvalvular atrial

[HTML][HTML] … and safety of extended treatment with direct oral anticoagulants for venous thromboembolism in Japan: A retrospective cohort study using claims data

H Hashimoto, S Imai, A Kiyomi, M Sugiura - Thrombosis Update, 2022 - Elsevier
… record of DOACs (apixaban, rivaroxaban, or edoxaban) at least … Bleeding risk of apixaban,
dabigatran, and low-dose … with non-valvular atrial fibrillation: a propensity matched analysis

[HTML][HTML] Real-world comparisons of low-dose Noacs versus standard-dose Noacs or warfarin on efficacy and safety in patients with AF: A meta-analysis

Z Li, X Wang, D Li, A Wen - Cardiology Research and Practice, 2022 - hindawi.com
warfarin were defined as dabigatran 150mgb.id, rivaroxaban … Salgado, “Risk of bleeding
with 2 doses of dabigatran … Xa inhibitor apixaban in Japanese patients with non-valvular atrial

Effectiveness and Safety of Direct Oral Anticoagulants in Thai Patients with Atrial Fibrillation: A Real-World Retrospective Cohort Study

S Srikajornlarp, M Amnueypol… - Clinical and Applied …, 2022 - journals.sagepub.com
… between AF patient groups receiving warfarin, dabigatran, rivaroxaban, and … the study on
Japanese administrative claims data 17 that apixaban harbored the lowest risk of any bleeding. …

[HTML][HTML] Starting dose and dose adjustment of non-vitamin K antagonist oral anticoagulation agents in a nationwide cohort of patients with atrial fibrillation

L Gozzo, A Di Lenarda, F Mammarella, PP Olimpieri… - Scientific Reports, 2021 - nature.com
… overtime for dabigatran and rivaroxaban; whereas prescription of low dose apixaban and
edoxaban … Compared with warfarin, low dose apixaban was associated with a 37% lower …

[HTML][HTML] Dabigatran for Japanese patients with atrial fibrillation and prior stroke: a subgroup analysis of the J-Dabigatran Surveillance program

…, J-Dabigatran Surveillance Investigators - Journal of Stroke and …, 2020 - Elsevier
risk of all-cause mortality and major bleeding including intracranial bleeding compared with
warfarin… /TIA, but not major bleeding, and commencement of rivaroxaban more than or equal …

[HTML][HTML] … bleeding between non-vitamin K antagonist oral anticoagulants and vitamin K antagonists in the Asian atrial fibrillation patients: A meta-analysis

KT Yang, WC Sun, TJ Tsai, FW Tsay, WC Chen… - International Journal of …, 2021 - mdpi.com
… taking different NOACs (rivaroxaban, dabigatran, apixaban, … Among them, apixaban seemed
to bring about the lowest risk of … ] had analyzed the GIB risk of standard-dose and low-dose

[HTML][HTML] Does warfarin or rivaroxaban at low anticoagulation intensity provide a survival benefit to Asian patients with atrial fibrillation?

D Lin, Y Chen, J Yong, S Wu, Y Zhou, W Li… - Frontiers in …, 2021 - frontiersin.org
… In this study, we investigate the survival benefits of low-dose … of thromboembolism and
hemorrhage in patients with non-valvular AF (… dabigatran and apixaban, for the warfarin group and …

[HTML][HTML] Influence of anticoagulants on the risk of delayed bleeding after gastric endoscopic submucosal dissection: a multicenter retrospective study

…, Y Hiasa, M Fujishiro, FIGHT-Japan Study Group - Gastric Cancer, 2021 - Springer
… , 92 patients received dabigatran, 103 rivaroxaban, 45 apixaban … group, because DOACs
are prescribed for non-valvular AF … consider dabigatran to be the better alternative for warfarin